Proposed Medicare Rule Threatens Remote Patient Monitoring and Access for Rural Seniors

For Dianne Williams, a resident of rural Georgia managing chronic health conditions, regular care used to involve arduous travel and uncertainty. Today, her routine includes quarterly doctor appointments, monthly coaching calls with a designated nurse, and a cellular-enabled blood pressure cuff that transmits daily physiological data directly to a clinical support team. This technological intervention has yielded tangible medical benefits, helping Williams lower her blood pressure, shed excess weight, and adopt sustainable lifestyle changes such as daily walking and dietary modifications.

Yet, the continued viability of these vital health tech services is in jeopardy. Under a controversial proposed federal rule issued by the Centers for Medicare & Medicaid Services (CMS), Medicare would soon halt reimbursements for healthcare providers who utilize third-party health technology companies to administer remote patient monitoring (RPM) programs. Should the policy take effect in its current form, Medicare would only compensate clinical providers when these services are administered directly by personnel physically located within the provider’s own facility.

This regulatory shift has sparked intense debate across the healthcare sector, pitting federal oversight agencies concerned with program integrity and billing practices against patient advocates, rural health providers, and digital health companies who argue the policy will disproportionately harm vulnerable populations and undermine years of digital health progress.

The Genesis of the Policy: Oversight, Fraud Concerns, and Federal Audits

The roots of the proposed CMS rule trace back to a series of federal audits and investigative reports published in 2024 and 2025 by the Department of Health and Human Services’ Office of Inspector General (OIG). As an independent oversight body, the OIG identified multiple vulnerabilities within the rapidly expanding remote patient monitoring market in traditional Medicare.

Among the primary concerns highlighted in the OIG reports were instances of aggressive marketing, potential billing fraud, insufficient data collection standards, and a troubling disconnect wherein patients frequently received monitoring and device management services from corporate vendors rather than the actual clinicians who initially prescribed the equipment. Federal regulators expressed growing apprehension that some commercial entities viewed RPM less as a clinical tool and more as a lucrative revenue-generation scheme.

CMS spokesperson Timothy Foster acknowledged the undeniable utility of technology-enabled care in expanding healthcare access, particularly in geographically isolated regions. However, Foster emphasized that the agency believes tighter regulatory guardrails are urgently required. The proposed rule argues that outside vendors frequently maintain little to no established clinical relationship with the patient, thereby fragmenting care and failing to demonstrate the level of direct clinician involvement necessary to justify continued taxpayer-funded reimbursement under the Medicare Physician Fee Schedule.

Chronology of Remote Patient Monitoring in Medicare

The integration of remote physiological monitoring into standard federal healthcare reimbursement is a relatively modern development that experienced exponential growth over a short timeframe:

• 2019–2020: The federal government formally established dedicated Medicare billing codes for remote patient monitoring during the first presidential term of Donald Trump. This policy change enabled healthcare providers to bill Medicare for initiating, setting up, and overseeing patient monitoring devices.
• 2019–2023: Program enrollment surged dramatically. According to data from the Peterson Center on Healthcare, the number of traditional Medicare beneficiaries enrolled in remote physiologic monitoring programs increased tenfold between 2019 and 2023. Concurrently, annual federal spending on these services escalated from just under $7 million to more than $194 million.
• 2024–2025: The HHS Office of Inspector General published its critical findings regarding program oversight, lack of physician engagement, and billing practices, prompting CMS to re-evaluate its payment policies.
• July 2025: CMS launched the ACCESS program, a new alternative payment model designed to test reimbursing both clinicians and vendors under value-based care frameworks, though initial reimbursement rates have been criticized as low.
• Late 2025: CMS published its proposed rule under the Physician Fee Schedule for the upcoming payment cycle, seeking to restrict third-party vendor involvement and eliminate reimbursements for services not administered directly within the provider’s physical facility.

Operational Realities for Rural and Underserviced Healthcare Systems

The debate over third-party vendors highlights a fundamental operational divide between large, well-resourced academic medical centers and smaller community health clinics operating in rural America.

Large health systems frequently possess the capital, IT infrastructure, and administrative bandwidth to build proprietary remote monitoring software, purchase hardware directly, and hire dedicated internal nursing staff to review incoming patient data streams. Conversely, rural healthcare facilities and community health centers often operate under severe financial constraints.

Edward Vance, the chief medical officer of Albany Area Primary Health Care—the clinical network serving Dianne Williams in Georgia—noted that his organization and similar safety-net providers frequently run on "shoestring budgets" with borderline understaffed teams. For these facilities, partnering with specialized third-party health tech vendors like CoachCare is not a matter of administrative convenience, but an operational necessity. Without external vendors to supply the devices, handle logistical onboarding, and provide initial data screening supported by artificial intelligence, rural clinics would be forced to abandon remote monitoring programs entirely.

Caroline Pearson, executive director of the nonpartisan Peterson Center on Healthcare, underscored the severity of this access barrier. Pearson stated that the proposed rule would "virtually eliminate the use of remote monitoring services, or dramatically reduce the use" across traditional Medicare, adding that rural communities will inevitably bear the brunt of the policy change due to geographic isolation and the severe shortage of local medical specialists.

Industry Backlash and Strategic Policy Misalignment

The publication of the CMS proposal caught the healthcare and technology sectors largely off guard. Andrew Van Ostrand, senior vice president at the Alliance for Connected Care—an organization advocating for the broad adoption of health technology—expressed astonishment that the administration pursued a total restriction on vendors rather than mandating stricter regulatory standards based on the OIG recommendations, many of which industry stakeholders had already begun voluntarily implementing.

A primary criticism leveled by industry advocates is that the proposed CMS rule represents a deep policy misalignment with other signature initiatives of the federal government. Specifically, critics point to President Donald Trump’s five-year, $50 billion Rural Health Transformation Program, which actively encourages states to deploy technological solutions and telehealth innovations to bridge rural healthcare gaps.

According to analyses by the Alliance for Connected Care, state governments have already earmarked at least $240 million from their initial allocations of rural health transformation funding specifically toward remote patient monitoring infrastructure. Industry leaders argue that crippling federal Medicare reimbursements for the exact same technology creates a counterproductive paradox that disrupts state-level modernization efforts.

By mid-September, more than 230 health technology vendors, prominent healthcare systems, and patient advocacy groups had formally signed an opposition letter urging CMS to reconsider its approach. Conversely, the proposal found backing among several major health industry players, including Humana, the Blue Cross Blue Shield Association, and Sutter Health—a major integrated health system that already maintains its own internal, proprietary remote monitoring infrastructure.

Financial Dynamics and the Path Toward Value-Based Care

While health tech advocates fight to preserve existing reimbursement pathways, policy analysts acknowledge that the rapid expansion of remote monitoring has not been entirely free of structural inefficiencies.

Data from the Peterson Center indicates that the average duration of remote monitoring enrollment for traditional Medicare patients increased from 1.7 months in 2019 to 5.2 months in 2023. Critics argue that while continuous monitoring is clinically indispensable for stabilizing acute conditions or managing unstable vitals, maintaining patients on long-term daily monitoring regimens long after their blood pressure or glucose levels have stabilized ceases to be driven by clinical necessity and begins to resemble a revenue-extraction model.

Pearson contends that the future of remote monitoring must pivot away from open-ended fee-for-service billing toward value-based reimbursement frameworks that tie financial compensation directly to measurable health outcomes. Regulators should consider imposing clear clinical duration limits—requiring formal re-evaluations before extending monitoring past stabilization—while demanding robust reporting standards from providers and vendors alike.

Although CMS has begun experimenting with value-based models through initiatives like the ACCESS program, health policy experts warn that abruptly dismantling current vendor-dependent models before alternative systems are mature risks stranding thousands of patients who rely on daily digital check-ins to stay out of the emergency room.

For patients like Dianne Williams, the policy debate translates into immediate personal anxiety. Sitting in her kitchen in rural Georgia after returning from a walk along a local trail, Williams voiced frustration over the federal government’s restrictive regulatory trajectory. As far as she and her care team are concerned, the monthly phone calls and data transmissions are not line items in a federal budget report, but a vital lifeline connecting her to continuous health management and personal encouragement.